Every year, employers invest heavily in January. New benefits roll out, communications increase, and engagement rises with it, creating a sense of early momentum. But that momentum rarely translates into sustained participation. In reality, only about one-third of employees are engaged at work, while the majority are either disengaged or actively disengaged, according to Gallup’s State of the Global Workplace findings.
By the time April arrives, that gap between enrollment and consistent behavior becomes clear. Some employees have established routines that continue, while others have gradually disengaged despite remaining enrolled.
Why April Is More Predictive Than January for Employee Health
January is driven by intention, while April reflects behavior. At the start of the year, employees are often more open to change, but that shift is typically short-lived. As routines stabilize and competing priorities return, early engagement narrows to the behaviors employees consistently maintain. For employers, this matters because healthcare costs are more closely associated with sustained behavior than with short-term engagement.
What this means in practice:
- Employees who remain engaged beyond the initial enrollment period tend to be more likely to sustain participation, as long-term outcomes are associated with consistency rather than initial sign-ups.
- Engagement often declines after initial program launch, and many employers report relatively low ongoing participation rates over time, according to workplace wellness participation data from Yuna.
- Q1 engagement data is directional, not definitive, reflecting early intent rather than sustained behavior.
- By April, engagement patterns begin to stabilize, making it an early indicator of which behaviors may persist and influence outcomes over time.

Where Employee Health Programs Break Down
By Q2, employees know what benefits are available. The issue is execution. Common approaches like emails and incentives drive awareness, not sustained behavior. As engagement drops, outcomes diverge, even when benefits remain the same.
Common breakdown signals:
- High enrollment but low participation, a common gap in workplace health programs where initial sign-ups do not translate into sustained use, as shown in RAND research on wellness program participation.
- Inconsistent engagement in chronic care programs, where adherence tends to decline over time without ongoing support.
- Limited structured follow-up when employees disengage, despite evidence that sustained intervention improves participation and outcomes.
- No clear connection between participation and measurable outcomes, making it difficult to track impact beyond initial activity.
Without consistent structure and follow-through, engagement typically declines after the initial launch period.

Why GLP-1 Programs Are Changing Employer Healthcare Costs
This pattern becomes even more pronounced in high-cost areas like GLP-1 medications. GLP-1 medications are quickly becoming one of the biggest variables in employer healthcare strategy.
The cost impact alone is hard to ignore. A recent analysis from WTW shows these medications now account for roughly 21% of pharmacy spend and up to 5% of total healthcare costs in some employer plans.
At the same time, demand is accelerating. Research from KFF Health System Tracker shows more employers are expanding coverage, even as they raise concerns about long-term affordability.
But the bigger issue is not just access, it’s consistency.
Real-world data from MedImpact shows that a large share of patients discontinue GLP-1 treatment within the first year, often restarting later. That start-stop pattern creates unpredictable outcomes and makes cost forecasting difficult.
When adherence holds, the picture changes.
A workforce-level analysis from Aon found that sustained GLP-1 use is associated with slower medical cost growth and improved health outcomes. More recent findings from Aon’s longitudinal research also point to reductions in hospitalizations and long-term health risks with consistent use.
That gap between access and adherence is where most employer strategies either succeed or fall apart.
The eMed GLP-1 program is designed to close that gap by pairing on-label, FDA approved medication with ongoing clinical oversight and accountability. Instead of relying on employees to self-manage, it builds in consistent touchpoints that support long-term engagement.
For employers, that leads to:
- More predictable utilization
- Higher sustained engagement
- Better alignment between cost and outcomes
By April, you can usually see which direction those patterns are heading.
What Employers Should Do in April
1. Focus on active engagement, not just enrollment
Enrollment doesn’t equal participation. Look at whether employees are actually following through.
2. Identify where drop-off happens
Pinpoint when engagement declines. That’s where friction exists.
3. Add structure where it’s missing
If there’s no accountability layer, disengagement will continue. Regular check-ins matter.
4. Reduce unnecessary complexity
The more fragmented the experience, the harder it is to sustain engagement.
5. Shift toward consistency-based outcomes
Programs should reward and support ongoing participation, not just initial sign-ups.

The Bottom Line
Employee health outcomes are shaped by what is sustained, not what starts strong. By April, those patterns are already visible, separating short-term engagement from consistent behavior.
For employers, that is where strategy begins to translate into measurable impact on outcomes and cost. To learn more visit https://www.emed.com/for-businesses/home
Disclaimer:
This content is for informational purposes only and does not constitute medical, legal, or financial advice. Third-party statistics and research cited are sourced from publicly available data and are provided for general context; results may vary by employer population. eMed's GLP-1 program pairs FDA-approved, on-label medications with clinical oversight; individual outcomes depend on a variety of factors. Employers should consult qualified advisors before making plan design or coverage decisions.




